# Guyana Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Guyana HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Guyana (GUY)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $3.4M
- Products: 27
- Buyer markets: 12
- Average CAGR: +4.8%
- Global sector size: $285.4B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $180.5B | $505.4K | $50.2B | -1.7% | 10 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $13.2B | $93.9K | $10.1B | +22.4% | 4 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $6.2B | $38.5K | $7.9B | +21.1% | 3 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $19.8B | $15.1K | $7.8B | -5.1% | 5 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $8.2B | $50.0K | $4.6B | -12.9% | 4 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $8.5B | $37.6 | $4.3B | +1.2% | 1 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $11.0B | $5.1K | $4.0B | +10.4% | 4 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $9.3B | $43.0 | $3.6B | -21.3% | 1 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $164.3 | $2.0B | -9.8% | 1 | +0.0% |
| HS 293590 - Sulphonamides: n.e.c. in heading no. 2935 | $1.9B | $17.3K | $1.5B | -17.0% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $3.7B | $411.0 | $1.4B | -10.7% | 2 | +0.0% |
| HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $1.6M | $1.4B | +52.8% | 1 | +0.9% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $1.8B | $7.5K | $1.2B | +12.0% | 1 | +0.0% |
| HS 300449 - Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $1.5B | $161.6 | $841.5M | +5.6% | 1 | +0.0% |
| HS 330590 - Hair preparations: n.e.s. in heading no. 3305 | $1.8B | $185.2 | $755.4M | -9.5% | 2 | +0.0% |
| HS 300431 - Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale | $952.3M | $8.8 | $753.2M | -24.1% | 1 | +0.0% |
| HS 310210 - Fertilizers, mineral or chemical: nitrogenous, urea, whether or not in aqueous solution | $2.3B | $298.7K | $746.5M | +69.8% | 1 | +0.0% |
| HS 300432 - Medicaments: containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | $1.9B | $6.4 | $746.4M | +15.7% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.1B | $114.7 | $719.0M | +0.4% | 1 | +0.0% |
| HS 284440 - Radioactive elements, isotopes, compounds, n.e.c. in heading no. 2844 alloys, dispersions (including cermets), ceramic products and mixtures containing these elements, isotopes or compounds: radioactive residues | $927.2M | $11.7K | $685.1M | -11.8% | 1 | +0.0% |
| HS 340600 - Candles, tapers and the like | $1.0B | $82.6 | $640.9M | +33.4% | 1 | +0.0% |
| HS 300660 - Pharmaceutical goods: chemical contraceptive preparations based on hormones or spermicides | $1.2B | $1.1K | $604.6M | +107.0% | 1 | +0.0% |
| HS 360410 - Pyrotechnic products: fireworks | $518.2M | $372.5 | $604.0M | -34.0% | 1 | +0.0% |
| HS 330749 - Perfumes and deodorizors: perfuming or deodorizing preparations for rooms, (excluding those which operate by burning) | $676.1M | $6.6 | $579.1M | +5.2% | 1 | +0.0% |
| HS 300510 - Dressings, adhesive: and other articles having an adhesive layer, packed for retail sale for medical, surgical, dental or veterinary purposes | $1.0B | $9.6 | $414.8M | +3.1% | 1 | +0.0% |
| HS 300590 - Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | $926.9M | $847.1 | $409.9M | +6.4% | 1 | +0.0% |
| HS 281820 - Aluminium oxide: other than artificial corundum | $609.1M | $719.2K | $368.5M | -3.1% | 1 | +0.1% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $57.2B calculated opportunity across 25 products.
- China (CHN): $8.6B calculated opportunity across 3 products.
- United Kingdom (GBR): $8.5B calculated opportunity across 5 products.
- Canada (CAN): $8.0B calculated opportunity across 6 products.
- Netherlands (NLD): $7.7B calculated opportunity across 4 products.
- Italy (ITA): $4.9B calculated opportunity across 1 products.
- Germany (DEU): $4.8B calculated opportunity across 1 products.
- France (FRA): $4.8B calculated opportunity across 4 products.
- Mexico (MEX): $2.1B calculated opportunity across 1 products.
- Brazil (BRA): $746.5M calculated opportunity across 1 products.
- Denmark (DNK): $721.7M calculated opportunity across 1 products.
- South Africa (ZAF): $677.5M calculated opportunity across 1 products.

## Growth stars

- HS 300660: +107.0% average CAGR, $604.6M calculated opportunity.
- HS 310210: +69.8% average CAGR, $746.5M calculated opportunity.
- HS 300670: +52.8% average CAGR, $1.4B calculated opportunity.
- HS 340600: +33.4% average CAGR, $640.9M calculated opportunity.
- HS 382499: +22.4% average CAGR, $10.1B calculated opportunity.
- HS 330210: +21.1% average CAGR, $7.9B calculated opportunity.
- HS 300432: +15.7% average CAGR, $746.4M calculated opportunity.
- HS 300390: +12.0% average CAGR, $1.2B calculated opportunity.
- HS 382200: +10.4% average CAGR, $4.0B calculated opportunity.
- HS 300590: +6.4% average CAGR, $409.9M calculated opportunity.

## Diversification opportunities

- HS 300490: 10 buyer markets, $50.2B calculated opportunity.
- HS 330499: 5 buyer markets, $7.8B calculated opportunity.
- HS 382499: 4 buyer markets, $10.1B calculated opportunity.
- HS 330300: 4 buyer markets, $4.6B calculated opportunity.
- HS 382200: 4 buyer markets, $4.0B calculated opportunity.
- HS 330210: 3 buyer markets, $7.9B calculated opportunity.
- HS 300290: 2 buyer markets, $1.4B calculated opportunity.
- HS 330590: 2 buyer markets, $755.4M calculated opportunity.
- HS 300212: 1 buyer markets, $4.3B calculated opportunity.
- HS 300439: 1 buyer markets, $3.6B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.